FibroBiologics, Inc. Common Stock

FBLGNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.03 USD
↘ 0.04 (3.74%)AT CLOSE (11:59 AM EDT)
1.00
↘ 0.03 (3.01%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
1.00
↘ 0.03 (3.01%)
🔴Market: CLOSED
Open?$1.07
High?$1.07
Low?$0.99
Prev. Close?$1.07
Volume?75.0K
Avg. Volume?288.4K
VWAP?$1.02
Rel. Volume?0.26x
Bid / Ask
Bid?$0.85 × 100
Ask?$1.20 × 100
Spread?$0.35
Midpoint?$1.02
Valuation & Ratios
Market Cap?5.6M
Shares Out?5.2M
Float?50.7M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?2.14
EPS?-$3.59
Dividend?0.00%
Ex-Dividend?N/A

FBLG is currently priced at $0.99. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, FBLG appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsLongevity & Aging›Age-Related Therapeutics
Employees
15
Market Cap
5.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fibrobiologics.com
Listed
2024-01-31
Address
455 E. MEDICAL CENTER BLVD
HOUSTON, TX 77598
Phone: 281-671-5150
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-22.28Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.47%Low
Short Interest?237.6K
Days to Cover?1.0
Free Float50.7M
Avg Daily Volume563.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?1.59Adequate
Quick Ratio?1.59Adequate
Cash Ratio?0.81Adequate
Debt/Equity?0.09Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.14CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-718.5%WEAK▾
ROA?
S&P
3
-314.6%WEAK▾
Cash Flow & Enterprise
FCF?$-15702000
Enterprise Value?$4.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist